{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:01:47Z","timestamp":1791115307333,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2006,7,19]],"date-time":"2006-07-19T00:00:00Z","timestamp":1153267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Although reproductive factors have been known for decades to be associated with breast cancer risk, it is unclear to what extent these associations differ by estrogen and progesterone receptor (ER\/PR) status. This report presents the first meta-analysis of results from epidemiological studies that have investigated parity, age at first birth, breastfeeding, and age at menarche in relation to ER<jats:sup>+<\/jats:sup>PR<jats:sup>+<\/jats:sup> and ER<jats:sup>-<\/jats:sup>PR<jats:sup>-<\/jats:sup> cancer risk.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Materials and methods<\/jats:title>\n                        <jats:p>We calculated summary relative risks (RRs) and corresponding 95% confidence intervals (CIs) using a fixed effects model.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Each birth reduced the risk of ER<jats:sup>+<\/jats:sup>PR<jats:sup>+<\/jats:sup> cancer by 11% (RR per birth = 0.89, 95% CI = 0.84\u20130.94), and women who were in the highest age at first birth category had, on average, 27% higher risk of ER<jats:sup>+<\/jats:sup>PR<jats:sup>+<\/jats:sup> cancer compared with women who were in the youngest age at first birth category (RR = 1.27, 95% CI = 1.07\u20131.50). Neither parity nor age at first birth was associated with the risk of ER<jats:sup>-<\/jats:sup>PR<jats:sup>-<\/jats:sup> cancer (RR per birth = 0.99, 95% CI = 0.94\u20131.05; RR of oldest versus youngest age at first birth category = 1.01, 95% CI = 0.85\u20131.20). Breastfeeding and late age at menarche decreased the risk of both receptor subtypes of breast cancer. The protective effect of late age at menarche was statistically significantly greater for ER<jats:sup>+<\/jats:sup>PR<jats:sup>+<\/jats:sup> than ER<jats:sup>-<\/jats:sup>PR<jats:sup>-<\/jats:sup> cancer (RR = 0.72 for ER<jats:sup>+<\/jats:sup>PR<jats:sup>+<\/jats:sup> cancer; RR = 0.84 for ER<jats:sup>-<\/jats:sup>PR<jats:sup>-<\/jats:sup> cancer, <jats:italic>p<\/jats:italic> for homogeneity = 0.006).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Our findings suggest that breastfeeding (and age at menarche) may act through different hormonal mechanisms than do parity and age at first birth.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr1525","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T19:59:11Z","timestamp":1153511951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":300,"title":["Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies"],"prefix":"10.1186","volume":"8","author":[{"given":"Huiyan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm C","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"key":"1493_CR1","first-page":"3232","volume":"42","author":"BE Henderson","year":"1982","unstructured":"Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res. 1982, 42: 3232-3239.","journal-title":"Cancer Res"},{"key":"1493_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"TJ Key","year":"1988","unstructured":"Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988, 24: 29-43. 10.1016\/0277-5379(88)90173-3.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1493_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","volume":"15","author":"L Bernstein","year":"1993","unstructured":"Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993, 15: 48-65.","journal-title":"Epidemiol Rev"},{"key":"1493_CR4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/oxfordjournals.epirev.a036295","volume":"8","author":"JL Stanford","year":"1986","unstructured":"Stanford JL, Szklo M, Brinton LA: Estrogen receptors and breast cancer. Epidemiol Rev. 1986, 8: 42-59.","journal-title":"Epidemiol Rev"},{"key":"1493_CR5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/oxfordjournals.epirev.a036107","volume":"15","author":"LA Habel","year":"1993","unstructured":"Habel LA, Stanford JL: Hormone receptors and breast cancer. Epidemiol Rev. 1993, 15: 209-219.","journal-title":"Epidemiol Rev"},{"key":"1493_CR6","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1158\/1055-9965.1558.13.10","volume":"13","author":"MD Althuis","year":"2004","unstructured":"Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME: Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev. 2004, 13: 1558-1568.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1493_CR7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/sj.bjc.6602712","volume":"93","author":"G Ursin","year":"2005","unstructured":"Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, et al: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer. 2005, 93: 364-371. 10.1038\/sj.bjc.6602712.","journal-title":"Br J Cancer"},{"key":"1493_CR8","unstructured":"Ma H, Bernstein L, Rose RK, Ursin G: Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res."},{"key":"1493_CR9","first-page":"319","volume":"4","author":"JD Potter","year":"1995","unstructured":"Potter JD, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR: Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?. Cancer Epidemiol Biomarkers Prev. 1995, 4: 319-326.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1493_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/jnci\/djh025","volume":"96","author":"GA Colditz","year":"2004","unstructured":"Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE: Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004, 96: 218-228.","journal-title":"J Natl Cancer Inst"},{"key":"1493_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/oxfordjournals.aje.a010265","volume":"151","author":"WY Huang","year":"2000","unstructured":"Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG: Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2000, 151: 703-714.","journal-title":"Am J Epidemiol"},{"key":"1493_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/aje\/kwf065","volume":"156","author":"JA Britton","year":"2002","unstructured":"Britton JA, Gammon MD, Schoenberg JB, Stanford JL, Coates RJ, Swanson CA, Potischman N, Malone KE, Brogan DJ, Daling JR, et al: Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20\u201344 years of age. Am J Epidemiol. 2002, 156: 507-516. 10.1093\/aje\/kwf065.","journal-title":"Am J Epidemiol"},{"key":"1493_CR13","first-page":"1053","volume":"12","author":"M Cotterchio","year":"2003","unstructured":"Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S: Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev. 2003, 12: 1053-1060.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1493_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/sj.bjc.6601293","volume":"89","author":"MR McCredie","year":"2003","unstructured":"McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL: Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer. 2003, 89: 1661-1663. 10.1038\/sj.bjc.6601293.","journal-title":"Br J Cancer"},{"key":"1493_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/oxfordjournals.aje.a009271","volume":"146","author":"KY Yoo","year":"1997","unstructured":"Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R: Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. Am J Epidemiol. 1997, 146: 307-314.","journal-title":"Am J Epidemiol"},{"key":"1493_CR16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cdp.2005.07.004","volume":"29","author":"J Rusiecki","year":"2005","unstructured":"Rusiecki J, Holford T, Zahm S, Zheng T: Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status. Cancer Detect Prev. 2005, 29: 419-426. 10.1016\/j.cdp.2005.07.004.","journal-title":"Cancer Detect Prev"},{"key":"1493_CR17","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","volume":"135","author":"S Greenland","year":"1992","unstructured":"Greenland S, Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992, 135: 1301-1309.","journal-title":"Am J Epidemiol"},{"key":"1493_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7: 177-188. 10.1016\/0197-2456(86)90046-2.","journal-title":"Control Clin Trials"},{"key":"1493_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315: 629-634.","journal-title":"BMJ"},{"key":"1493_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1016361932220","volume":"74","author":"KC Chu","year":"2002","unstructured":"Chu KC, Anderson WF: Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial\/ethnic groups. Breast Cancer Res Treat. 2002, 74: 199-211. 10.1023\/A:1016361932220.","journal-title":"Breast Cancer Res Treat"},{"key":"1493_CR21","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1023\/A:1008970121595","volume":"10","author":"Y Yasui","year":"1999","unstructured":"Yasui Y, Potter JD: The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control. 1999, 10: 431-437. 10.1023\/A:1008970121595.","journal-title":"Cancer Causes Control"},{"key":"1493_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/bcr452","volume":"4","author":"E Anderson","year":"2002","unstructured":"Anderson E: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002, 4: 197-201. 10.1186\/bcr452.","journal-title":"Breast Cancer Res"},{"key":"1493_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/oxfordjournals.jncimonographs.a024237","volume":"27","author":"RB Dickson","year":"2000","unstructured":"Dickson RB, Stancel GM: Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr. 2000, 27: 135-145.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"1493_CR24","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1126\/science.3283939","volume":"240","author":"RM Evans","year":"1988","unstructured":"Evans RM: The steroid and thyroid hormone receptor superfamily. Science. 1988, 240: 889-895.","journal-title":"Science"},{"key":"1493_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.ph.38.030176.002233","volume":"38","author":"J Gorski","year":"1976","unstructured":"Gorski J, Gannon F: Current models of steroid hormone action: a critique. Annu Rev Physiol. 1976, 38: 425-450. 10.1146\/annurev.ph.38.030176.002233.","journal-title":"Annu Rev Physiol"},{"key":"1493_CR26","first-page":"741","volume":"74","author":"L Bernstein","year":"1985","unstructured":"Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE: Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst. 1985, 74: 741-745.","journal-title":"J Natl Cancer Inst"},{"key":"1493_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/ijc.10651","volume":"102","author":"M Garcia-Closas","year":"2002","unstructured":"Garcia-Closas M, Herbstman J, Schiffman M, Glass A, Dorgan JF: Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer. 2002, 102: 172-178. 10.1002\/ijc.10651.","journal-title":"Int J Cancer"},{"key":"1493_CR28","first-page":"381","volume":"4","author":"JF Dorgan","year":"1995","unstructured":"Dorgan JF, Reichman ME, Judd JT, Brown C, Longcope C, Schatzkin A, Campbell WS, Franz C, Kahle L, Taylor PR: Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Biomarkers Prev. 1995, 4: 381-386.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1493_CR29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/oxfordjournals.epirev.a036115","volume":"15","author":"JL Kelsey","year":"1993","unstructured":"Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev. 1993, 15: 36-47.","journal-title":"Epidemiol Rev"},{"key":"1493_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.tem.2004.05.011","volume":"15","author":"G Dontu","year":"2004","unstructured":"Dontu G, El-Ashry D, Wicha MS: Breast cancer, stem\/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004, 15: 193-197. 10.1016\/j.tem.2004.05.011.","journal-title":"Trends Endocrinol Metab"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr1525\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr1525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:58:45Z","timestamp":1728385125000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr1525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2006,8]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/bcr1525","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,19]]},"assertion":[{"value":"28 March 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2006","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2006","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R43"}}